|
Bento L, Gutierrez A, Novelli S, Montoro J, Pinana JL, Lopez-Corral L, Cabrero M, Martin-Sancho A, Gutierrez-Garcia G, Ortiz-Moscovich M, Bastos-Oreiro M, Dorado N, Perez A, Hernani R, Ferra C, Parody R, Garcia-Cadenas I, Herrera P, Rodriguez G, Rodriguez N, Martin C, Yanez L, Zanabili J, Varela MR, Lopez-Godino O, Heras I, Espanol I, Martinez C, Perez-Simon JA, Solano C, Sureda A, Sierra J, Sampol A, Caballero D; Grupo Espanol de Trasplante Hematopoyetico (GETH) and Grupo Espanol de Linfoma y Trasplante Autologo (GELTAMO). Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study. Bone Marrow Transplant. 2021 Aug;56(8):1919-1928. doi: 10.1038/s41409-021-01264-3. Epub 2021 Mar 25. PubMed PMID: 33767400.
AÑO: 2021; IF: 5.174
|
|
Parra Salinas I, Bermudez A, Lopez Corral L, Lopez Godino O, Moles-Poveda P, Martin G, Costilla Barriga L, Ferra Coll C, Marquez-Malaver F, Orti G, Zudaire Ripa MT, Rifon J, Martinez C; Spanish Group of Hematopoietic Transplantation (GETH). Treatment of steroid-refractory chronic graft-versus-host disease with imatinib: Real-life experience of the Spanish group of hematopoietic transplantation (GETH). Clin Transplant. 2021 May;35(5):e14255. doi: 10.1111/ctr.14255. Epub 2021 Mar 1. PubMed PMID: 33595866.
AÑO: 2021; IF: 3.456
|
|
Hernandez-Boluda JC, Pereira A, Alvarez-Larran A, Martin AA, Benzaquen A, Aguirre L, Mora E, Gonzalez P, Mora J, Dorado N, Sampol A, Garcia-Gutierrez V, Lopez-Godino O, Fox ML, Reguera JL, Perez-Encinas M, Pascual MJ, Xicoy B, Parody R, Gonzalez-Pinedo L, Espanol I, Avendano A, Correa JG, Vallejo C, Jurado M, Garcia-Cadenas I, Osorio S, Duran MA, Sanchez-Guijo F, Cervantes F, Pinana JL. Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model. Biol Blood Marrow Transplant. 2020 Dec;26(12):2237-2244. doi: 10.1016/j.bbmt.2020.07.022. Epub 2020 Jul 24. PubMed PMID: 32717433.
AÑO: 2020; IF: 5.742
|
|
Carrillo-Cruz E, Garcia-Lozano JR, Marquez-Malaver FJ, Sanchez-Guijo FM, Montero Cuadrado I, Ferra I Coll C, Valcarcel D, Lopez-Godino O, Cuesta M, Parody R, Lopez-Corral L, Alcoceba M, Caballero-Velazquez T, Rodriguez-Gil A, Bejarano-Garcia JA, Ramos TL, Perez-Simon JA. Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms. Clin Cancer Res. 2019 Aug 1;25(15):4616-4623. doi: 10.1158/1078-0432.CCR-18-3875. Epub 2019 May 1. PubMed PMID: 31043390.
AÑO: 2019; IF: 10.107
|
|
Bastida JM, Lopez-Godino O, Vicente-Sanchez A, Bonanad-Boix S, Xicoy-Cirici B, Hernandez-Sanchez JM, Such E, Cervera J, Caballero-Berrocal JC, Lopez-Cadenas F, Arnao-Herraiz M, Rodriguez I, Llopis-Calatayud I, Jimenez MJ, Del Canizo-Roldan MC, Diez-Campelo M. Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology. Int J Lab Hematol. 2019 Feb;41(1):109-117. doi: 10.1111/ijlh.12933. Epub 2018 Oct 5. PubMed PMID: 30290085.
AÑO: 2019; IF: 2.141
|
33767400